Clover Health Investments... (CLOV)
Clover Health Investments Corp. (CLOV) Stock Price, Analysis & Data
| Бид | 3.29 |
| Рыночная капитализация | 2.44B |
| Выручка (TTM) | 2.48B |
| Чистая прибыль (TTM) | -18.36M |
| Бета | 2.48 |
| EPS (TTM) | -0.05 |
| P/E (TTM) | n/a |
| Прогнозный P/E | 30.67 |
| P/B (TTM) | 6.47 |
| P/S (TTM) | 0.99 |
| Earnings Date | Nov 4, 2025 |
| Аск | 5.76 |
| Объём торгов | 3,566,871 |
| Ср. объём (20д) | 6,920,106 |
| Открытие | 4.47 |
| Пред. закрытие | 4.49 |
| Диапазон дня | 4.45 - 4.63 |
| Диапазон за 52 недели | 1.58 - 5.59 |
| Аналитики | Buy |
| Целевая цена | 5 (8.70%) |
| Дивиденды | n/a |
| Дата отсечки | n/a |
О компании CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware....
Финансовые результаты
В 2025 году выручка Clover Health Investments составила 1.92B — это рост на 40.34% к прошлогодним 1.37B. Прибыль составила -85.55M — это рост на 98.91%.
Финансовая отчётностьПрогноз аналитиков
По 3 оценкам аналитиков средний рейтинг акций CLOV — «Buy». Прогноз цены на 12 месяцев — 5, это потенциал роста на 8.7% от последней цены.
Прогнозы по акцииСюрприз в отчёте
Аналитики ждут выручку ... Улучшить тариф

7 часов назад · Simply Wall St.
Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up with valuation checks that suggest the stock no longer looks ...

16 часов назад · Simply Wall St.
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10....



